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Although residents of Lyme disease–endemic regions
describe frequent exposure to ticks, Lyme disease devel-
ops in relatively few. To determine whether people who
experience cutaneous hypersensitivity against tick bite
have fewer episodes of Lyme disease than those who do
not, we examined several factors that might restrict the inci-
dence of Lyme disease among residents of Block Island,
Rhode Island. Of 1,498 study participants, 27% (95% con-
fidence interval [CI] 23%–31%) reported >1 tick bites, and
17% (95% CI 13%–21%) reported itch associated with tick
bite in the previous year. Borrelia burgdorferi infected 23%
(95% CI 20%–26%) of 135 nymphal Ixodes scapularis (I.
dammini) ticks. The likelihood of Lyme disease infection
decreased with >3 reports of tick-associated itch (odds
ratio 0.14, 95% CI 0.94–0.03, p = 0.01). Prior exposure to
vector ticks protects residents of disease-endemic sites
from Lyme disease.
A
lthough many residents of Lyme disease–endemic
regions describe frequent exposure to ticks, relatively
few become infected by the causative spirochetal agent,
Borrelia burgdorferi (1–4). This disparity reflects both a
relative paucity of spirochetal infection in vector ticks and
the limited number of people actually bitten by ticks (5–6).
Other variables that might restrict Lyme disease incidence
include prompt removal of attached ticks before the
pathogen is transmitted and acquired immunity to the sali-
vary proteins of these ticks, the spirochetal pathogen, or
both (7–11).Repeated exposure to tick bites has been asso-
ciated with developing cutaneous hypersensitivity, which
results in persistent itch and local swelling at the site of
tick attachment (12–13). Itching provides an early sign of
tick bite and may facilitate removal of the attached tick
before the pathogen can be transmitted. Additional inflam-
matory reaction to tick salivary proteins also may help pre-
vent transmission (10–11). The epidemiologic relevance of
host immunity to tick bite for preventing Lyme disease
remains unknown.
Acquired immunity to vector ticks may limit the inci-
dence of Lyme disease by protecting persons who have
been previously exposed to bites of vector ticks.
Accordingly, we determined whether cutaneous hypersen-
sitivity against tick antigens increases with the frequency
of tick exposure and whether such reactivity protects
against Lyme disease. In particular, we determined
whether residents of Block Island, Rhode Island, who
experienced itching associated with attached ticks have
fewer episodes of Lyme disease than those who report no
episodes of itching associated with tick attachment. 
Methods
Study Site and Sampling Procedures
Block Island is located 15 km from the New England
mainland, and Lyme disease is highly endemic there.
Beginning in 1991, we invited all residents to participate in
a serosurvey twice yearly (during October and April). We
sought to identify all cases of infection due to B. burgdor-
feri among serosurvey participants with the help of the
staff of the Block Island Medical Center, the sole medical
facility on the island, and by a dedicated research nurse
(3). Borrelial infections were identified among members of
the study cohort who visited the medical center for an
acute tickborne illness or who seroconverted against bor-
relial antigen during the study period. Written informed
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Data Collection
At the serosurvey visit, participants submitted a blood
sample and responded to a questionnaire about tick bites,
use of protective measures, exposure factors, and symp-
toms of tickborne illness during the previous year
(Figure 1). Specifically, they were asked if they had expe-
rienced a tick bite in the previous year and whether their
tick bites produced itch. Amedical history, physical exam-
ination, and specific Lyme disease laboratory tests were
performed on all symptomatic participants at the time of
suspected Lyme disease illness and 4–6 weeks later. A
medical history was repeated at least every 3 months until
the participants became asymptomatic. Ixodes scapularis
ticks (I. dammini) were collected in May through October
from 1991 through 2000 by flagging at diverse sites on the
island. Ticks were analyzed for B. burgdorferi by poly-
merase chain reaction (PCR).
PCR Assay for Spirochete DNA
Whole blood samples were analyzed and processed by
personnel blinded to the clinical status of the donor, as pre-
viously described (14). DNA extraction was performed on
blood from Lyme disease patients and on Ixodes ticks with
a commercially available kit (IsoQuick Nucleic Acid
Extraction Kit, ORCA Research, Bothell, WA) (14,15). A
294-bp portion of the B. burgdorferi OspA gene was tar-
geted for amplification by using a previously described
PCR protocol (14,15).
Assays for Antispirochetal Antibody
Serologic evidence of exposure to the Lyme disease
spirochete was detected by enzyme-linked immunosorbent
assay (16).Areactive serum was defined as one with a pos-
itive reaction at a dilution >1:320. All borderline or reac-
tive sera were further characterized by immunoblot
(16,17). Specimens were considered positive if the
immunoglobulin (Ig) G immunoblot contained >5 of the
10 most common B. burgdorferi–specific bands (17).
Case Definition
To include both symptomatic and asymptomatic cases
of Lyme disease, diagnosis of newly acquired B. burgdor-
feri infection during the course of the study required one of
the following: 1) a physician diagnosis of erythema
migrans consisting of an expanding, ringlike erythematous
rash at least 5 cm in diameter; 2) influenzalike symptoms
consistent with Lyme disease and laboratory evidence of
recent infection; 3) seroconversion from an initial nonre-
active serum to a subsequent reactive serum that contained
anti-B. burgdorferi antibody. The influenzalike symptoms
of Lyme disease include fever, chills, sweats, fatigue,
headache, or myalgia. Laboratory evidence of recent infec-
tion included either amplification of B. burgdorferi DNA
in blood by PCR, seroconversion, or a 4-fold rise in anti-
B. burgdorferi antibody in paired acute-phase and conva-
lescent-phase sera.
Predicted and Observed Lyme Disease Rates
A simple model of Lyme disease transmission would
calculate the rate of Lyme disease infection as the product
of 2 main factors: the proportion of persons who report
being bitten by deer ticks and the proportion of these ticks
infected by B. burgdorferi. We calculated the yearly inci-
dence of Lyme disease by determining the number of sero-
survey participants who met the Lyme disease case
definition each year in relation to the number of partici-
pants enrolled each year. By comparing the projected inci-
dence using the Lyme disease transmission model to actual
incidence of Lyme disease, we could assess the overall
importance of factors missing from the basic model, such
as the effects of inflammatory reactions against tick sali-
vary proteins and acquired immunity to the spirochetal
pathogen.
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Figure 1. Standardized serosurvey questionnaire used to gather
tick exposure history.Statistical Analysis
All statistical calculations were performed with JMP
5.1 (SAS Institute, Cary, NC). To estimate the study sam-
ple frequency of tick bite and tick-associated itch, we aver-
aged the individual reports of tick bite and tick-associated
itch among study participants each year. To determine
yearly Lyme disease incidence, we compared the number
of new cases of Lyme disease each year to the total num-
ber of study participants who had enrolled in the study up
to that time. To create 10-year individual measures, reports
of tick bite and itch were summed across all visits for each
participant. The results were analyzed with descriptive
statistics (mean, proportion, and confidence intervals with
5% error). Bivariate logistic regression was used to esti-
mate probability of itch for increasing tick bites. The rela-
tive contribution of risk factors to the acquisition of Lyme
disease was evaluated from multiple logistic regression
models to calculate odds ratios with associated confidence
limits. The predicted probability of acquiring Lyme dis-
ease was estimated for significant risk factors.
Results
A total of 1,669 residents of Block Island, most of the
island population, enrolled in our study from 1991 to 2000.
We excluded those participants who did not report spend-
ing at least 1 month on the island during May through
October, which resulted in a sample of 1,490. The mean
age of the sample was 43 years (95% CI 42.2–44.1) and
approximately half (51%) were female. 
We determined how frequently the 1,490 persons in our
sample recalled a deer tick bite. Each year an average of
27% (95% CI 23%–31%) of the study participants report-
ed >1 tick bite during the prior year (range 20%–37%). An
average of 17% (95% CI 13%–21%) of study participants
reported itch associated with tick bite (Figure 2).
We then determined the prevalence of B. burgdorferi
infection in nymphal deer ticks that contained B. burgdor-
feri DNA and that were swept from vegetation on Block
Island throughout the course of this study. Of 135 such ticks
tested, 23% (95% CI 20%–26%) contained amplifiable
B. burgdorferi DNA. We therefore predicted that the maxi-
mum yearly incidence of Lyme disease would be 6.2%
(95% CI 4.6%–8.1%) (27% with tick bite x 23% of ticks
infected).
We next calculated yearly incidence rate of new Lyme
disease cases among study participants from 1991 to 2000.
The average incidence was 1.74% (95% CI 1.1%–2.4%)
(Table). Thus, the predicted incidence of Lyme disease
using the basic model (95% CI 4.6%–8.1%) was 3%–6%
greater than the observed incidence. This difference would
not be expected due to chance.
We next determined whether increasing exposure to
ticks increases the probability of tick-associated itch. This
analysis was limited to participants whose sera displayed
no evidence of tickborne illness before study entry, who
had >1 serosurvey visit, and who were >2 years of age.
Among these 610 participants, 52% reported at least 1 tick
bite (mean 2.2, 95% CI 2.0–2.4), and 32% reported itch
with any tick bite. The probability of itch doubled as the
number of reported tick bites increased from 1 to 2 (21%
to 46%, respectively) and doubled again from 2 to 4
reported bites (46% to 97%, respectively; linear trend
p < 0.001). 
Finally, we tested the hypothesis that tick-associated
itching is associated with decreased risk of Lyme disease.
The acquisition of Lyme disease increased from 15% to
25% to 31% among participants who reported no itch, 1
episode of tick-associated itch, and 2 reports of itch,
respectively. In contrast, the frequency of Lyme disease
decreased to 13% in participants who reported 3 episodes
of tick-associated itch and 10% in those with >4 such
reports. We used a multiple logistic regression model to
estimate the likelihood of acquiring Lyme disease for par-
ticipants reporting none to 1, 2, and >3 reports of itch, con-
trolling for number of study visits and reports of tick bite.
Consistent with the bivariate analysis, the risk of acquiring
Lyme disease was higher for 1 report of itch (OR 2.7, 95%
CI 0.4–2.3), and decreased among those who reported itch
at >3 study visits (range 3–12, OR 0.18, 95% CI 0.05–0.5)
(Figure 3). Confining the analysis to only those who had
Lyme disease illness by omitting participants whose evi-
dence of Lyme disease was by seroconversion alone did
not alter the inverse relationship between itch and devel-
oping Lyme disease. Persons who consistently report itch-
ing in association with tick bites are less likely to
experience an episode of Lyme disease than do those who
fail to react against tick bite.
Discussion
These observations suggest that residents of disease-
endemic sites who experience persistent tick-associated
itch are less likely to develop Lyme disease than are those
RESEARCH
38 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 11, No. 1, January 2005
Figure 2. Reported tick bite and itch by serosurvey year on Block
Island, Rhode Island, 1991–2000.who do not experience this reaction. Itch was reported at
the site of tick bite, and the frequency of itch increases as
the number of reported tick bites increase, which strongly
suggests that tick-associated itch is linked to an acquired
cutaneous hypersensitivity response. Such a relationship
has definitively been established in the case of I. ricinis,
the European analog of the North American deer tick.
After having been bitten by these ticks repeatedly, persons
experience both immediate and delayed cutaneous hyper-
sensitivity reactions. They express tick-specific IgE anti-
bodies, as well as dermal and perivascular infiltrates of
CD8+ T lymphocytes and Langerhans’ cells (13).
Additional studies of other tick species also suggest that
tick-associated itch is mediated by tick-specific antibody
or cellular infiltration (12,18,19). People in our study who
reported a single episode of tick-associated itch were more
likely to acquire Lyme disease than those who did not
report itch, probably because tick-associated itch is a
marker for tick exposure. In contrast, persons who had
repeated tick-associated itch were protected from develop-
ing Lyme disease. We are confident, therefore, that the
people in our study who described repeated episodes of
tick-associated itching were experiencing cutaneous
hypersensitivity and that this immune reaction protected
them from acquiring Lyme disease.
The antitick immune response that protects people from
acquiring Lyme disease might act through any of several
effector mechanisms. A heightened awareness by a person
of an attached tick would result in the removal of the
potentially infecting tick before pathogen transmission
could occur. Because vector ticks must remain attached for
at least 2 days before spirochetes are transmitted, prompt
tick removal should prevent spirochetal infection (8,20).
Vector ticks generally are removed by persons within such
a time period (21–23). Alternatively, immunity against tick
salivary antigens might interfere with pathogen transmis-
sion independent of early host recognition and removal of
ticks. Indeed, preexposure of mice and guinea pigs to unin-
fected ticks prevents Lyme disease after challenge by
spirochete-infected ticks using infestation conditions that
prevent removal of feeding ticks by host grooming (24,25).
Ticks feeding on such immune hosts detach sooner and
retain less host material than do ticks feeding on nonim-
mune hosts. Although natural hosts, such as Peromyscus
leucopus, do not develop robust antitick immunity, inbred
strains of mice and guinea pigs become immune to the sali-
vary antigens secreted by feeding ticks (10,26,27). This
immunity results in reduced volume of engorgement,
abnormal blood meal composition, prolonged feeding, and
frequently death of the tick (10,27). Antitick immunity
may specifically neutralize some components of tick sali-
va that ensure successful feeding and facilitate pathogen
transmission, such as vasodilators, anticoagulants, and
immunosuppressors (10,11,28). Prevention of B. burgdor-
feri transmission in guinea pigs is associated with antivec-
tor antibody (25). Persons who experience frequent deer
tick bites produce an array of specific antitick antibodies
(29–31). Cell-mediated immune factors against tick-
derived antigen might similarly play a role in developing
cutaneous hypersensitivity and protect against infection
(13,19). A strong delayed cutaneous hypersensitivity
response to sandfly bites in persons has been correlated
with reduced transmission of leishmanial parasites (32,33).
An array of antitick immune reactions may prevent Lyme
disease and other tickborne diseases.
Our analysis incorporates several potentially confound-
ing assumptions. Although our estimate of the prevalence
of spirochetal infection in vector ticks is based on a small
sample of ticks, this rate is consistent with that derived in
other parts of southern New England at approximately the
same time (5,6). Although our study participants live on
Block Island where deer ticks predominate, some of our
participants may have been bitten by other kinds of ticks or
been bitten by ticks off the island. While approximately a
quarter of our participants reported a tick bite, previous
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Figure 3. Risk of acquiring Lyme disease according to reports of
tick bite–associated itch. studies have shown that persons are often unaware that
they have been bitten. From a third to three fourths of
patients with Lyme disease cannot recall having been bit-
ten by a tick (6,34–36). Assuming that a similar percentage
of our study participants were unaware of a previous tick
bite, the tick bite prevalence on Block Island would have
varied from half to all of our participants. Atick bite preva-
lence of 71% was reported at another site where Lyme dis-
ease is highly endemic (37). Any underestimate of the
frequency of tick attachment would increase the likelihood
that other factors, including antitick immunity, help limit
the incidence of Lyme disease. Finally, our predicted Lyme
disease incidence assumes that people are bitten only once
in any year. An increase in yearly tick bite frequency
among persons would increase the likelihood that the tick
bite is from an infected tick, thus similarly increasing the
difference between predicted and observed incidence rates.
We believe that none of these assumptions is notably con-
founding.
Several factors help prevent Lyme disease in persons
who live in disease-endemic regions. These factors include
the paucity of ticks that are infected with the Lyme spiro-
chete, the limited number of persons who are bitten by
ticks, acquired immunity against the spirochetal pathogen,
and the immune reaction to ticks that develops in the
course of tick attachment. Persons who express an immune
reaction against the vector tick appear to acquire Lyme dis-
ease less frequently than do those who experience no such
immune reaction. The protective effect of the immune
response to tick salivary protein against the agent of Lyme
disease in persons suggests that a tick protein-based vac-
cine might be developed that would protect against infec-
tion by the agent of Lyme disease and possibly other
tickborne infections. 
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